Lost in application: Measuring hypoxia for radiotherapy optimisation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lost in application: Measuring hypoxia for radiotherapy optimisation
Authors
Keywords
Biomarker, Gene expression, Hypoxia, Hallmarks of cancer, Radiotherapy, Hypoxia modification
Journal
EUROPEAN JOURNAL OF CANCER
Volume 148, Issue -, Pages 260-276
Publisher
Elsevier BV
Online
2021-03-21
DOI
10.1016/j.ejca.2021.01.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From Anemia to Erythropoietin Resistance in Head and Neck Squamous Cell Carcinoma Treatment: A Carousel Driven by Hypoxia
- (2020) Grazia Lazzari et al. OncoTargets and Therapy
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
- (2019) Pernille Elming et al. Cancers
- The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
- (2019) Peter Vaupel et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer
- (2019) Weranja K.B. Ranasinghe et al. BJU INTERNATIONAL
- Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients
- (2019) Martijn van der Heijden et al. Cancers
- Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
- (2019) Sue Harnan et al. HEALTH TECHNOLOGY ASSESSMENT
- Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb)
- (2019) Indrani S. Bhattacharya et al. RADIOTHERAPY AND ONCOLOGY
- The Potential Role of Radiomics and Radiogenomics in Patient Stratification by Tumor Hypoxia Status
- (2019) Loredana G. Marcu et al. Journal of the American College of Radiology
- Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy
- (2018) Lingjian Yang et al. BRITISH JOURNAL OF RADIOLOGY
- Role of metabolism in cancer cell radioresistance and radiosensitization methods
- (2018) Le Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy
- (2018) Rong Wang et al. Oncotarget
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
- (2018) Lingjian Yang et al. EBioMedicine
- Targeting the vasculature of tumours: combining VEGF pathway inhibitors with radiotherapy
- (2018) Chryso Kanthou et al. BRITISH JOURNAL OF RADIOLOGY
- Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI
- (2018) James O'Connor et al. BRITISH JOURNAL OF RADIOLOGY
- Time to abandon single-site irradiation for inducing abscopal effects
- (2018) Eric D. Brooks et al. Nature Reviews Clinical Oncology
- Hypoxia Modification during Prostate Radiation Therapy Using Carbogen and Nicotinamide: Toxicity Results from a Phase 2 Study (PROCON)
- (2017) N. Thiruthaneeswaran et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis
- (2017) Y. Hu et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18 F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
- (2017) Pierre Vera et al. JOURNAL OF NUCLEAR MEDICINE
- Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
- (2017) Steffi U. Pigorsch et al. Radiation Oncology
- Expression of hypoxia inducible factor 1 alpha and its clinical significance in esophageal carcinoma: A meta-analysis
- (2017) Shao Wu Jing et al. TUMOR BIOLOGY
- Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis
- (2017) Jianhua Zhou et al. World Journal of Surgical Oncology
- Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
- (2017) Gerben R. Borst et al. Oncotarget
- Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
- (2017) Lingjian Yang et al. Oncotarget
- Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials
- (2016) Kasper Toustrup et al. ACTA ONCOLOGICA
- QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
- (2016) Paul G. O’Reilly et al. BMC BIOINFORMATICS
- Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
- (2016) Liam Welsh et al. BRITISH JOURNAL OF CANCER
- Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
- (2016) Christina S. Fjeldbo et al. CLINICAL CANCER RESEARCH
- Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
- (2016) Johannes Schödel et al. EUROPEAN UROLOGY
- Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
- (2016) Niloy R. Datta et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
- (2016) Sheng-li Yang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- The impact of hypoxia and its modification of the outcome of radiotherapy
- (2016) Michael R. Horsman et al. JOURNAL OF RADIATION RESEARCH
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
- (2016) Vincent Picco et al. Oncotarget
- Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis
- (2016) Yongjiang Li et al. SpringerPlus
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- (2016) Simon J. A. van Kuijk et al. Frontiers in Oncology
- Hypoxia dose painting in prostate and cervix cancer
- (2015) Peter J. Hoskin ACTA ONCOLOGICA
- Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
- (2015) Jens Bentzen et al. ACTA ONCOLOGICA
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole
- (2015) N C Dhani et al. BRITISH JOURNAL OF CANCER
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- Gene Expression Signatures as Biomarkers of Tumour Hypoxia
- (2015) B.H.L. Harris et al. CLINICAL ONCOLOGY
- NF-κB and HIF crosstalk in immune responses
- (2015) Laura D'Ignazio et al. FEBS Journal
- Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis
- (2015) Niloy R. Datta et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- The End of the Hypoxic EPOch
- (2015) Todd A. Aguilera et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
- (2015) Encouse B Golden et al. LANCET ONCOLOGY
- A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers
- (2015) Marije Oosterhoff et al. Applied Health Economics and Health Policy
- Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
- (2015) Julie Sesen et al. PLoS One
- The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
- (2014) H B Ragnum et al. BRITISH JOURNAL OF CANCER
- Imaging tumour hypoxia with positron emission tomography
- (2014) I N Fleming et al. BRITISH JOURNAL OF CANCER
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
- (2014) Geert O. Janssens et al. CLINICAL CANCER RESEARCH
- The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
- (2014) E.M. Hammond et al. CLINICAL ONCOLOGY
- NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer
- (2014) D. Thomson et al. CLINICAL ONCOLOGY
- Hypoxia Signaling and the Metastatic Phenotype
- (2014) H. Mujcic et al. CURRENT MOLECULAR MEDICINE
- The Effect of Carbogen Breathing and Nicotinamide Added to Standard (Chemo)Radiation Treatment of Advanced Cervical Cancer in Indonesia
- (2014) Willem Jan van Weelden et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study
- (2014) Paul A. DiSilvestro et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer
- (2014) Ana Boladeras et al. RADIOTHERAPY AND ONCOLOGY
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
- (2013) A. Eustace et al. CLINICAL CANCER RESEARCH
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Biomarker enrichment strategies: matching trial design to biomarker credentials
- (2013) Boris Freidlin et al. Nature Reviews Clinical Oncology
- Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
- (2013) Christopher P. Guise et al. Chinese Journal of Cancer
- Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
- (2013) Matteo Bellone et al. Frontiers in Oncology
- Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks
- (2012) Xuping Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer
- (2012) Rupesh Kotecha et al. Brachytherapy
- Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI
- (2012) C. Halle et al. CANCER RESEARCH
- Lysyl Oxidase: From Basic Science to Future Cancer Treatment
- (2012) Takeshi Nishioka et al. CELL STRUCTURE AND FUNCTION
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
- (2012) Guy N.J. Betts et al. EUROPEAN JOURNAL OF CANCER
- Investigation of possible endogenous hypoxia markers in colorectal cancer
- (2012) Maud Verstraete et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability
- (2012) R. Kumareswaran et al. JOURNAL OF CELL SCIENCE
- Imaging hypoxia to improve radiotherapy outcome
- (2012) Michael R. Horsman et al. Nature Reviews Clinical Oncology
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
- (2012) Peter J. Hoskin et al. RADIOTHERAPY AND ONCOLOGY
- Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials
- (2011) Camilla Molich Hoff et al. ACTA ONCOLOGICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hypoxic Prostate/Muscle Po2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results
- (2011) Aruna Turaka et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
- (2011) J. M. Senra et al. MOLECULAR CANCER THERAPEUTICS
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
- (2011) Jens Overgaard RADIOTHERAPY AND ONCOLOGY
- Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
- (2011) Kasper Toustrup et al. RADIOTHERAPY AND ONCOLOGY
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
- (2010) J Glaspy et al. BRITISH JOURNAL OF CANCER
- The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
- (2010) C. O. Marian et al. CLINICAL CANCER RESEARCH
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
- (2010) Lester J. Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
- (2010) Paolo Fardin et al. Molecular Cancer
- Radiation-induced cell death mechanisms
- (2010) David Eriksson et al. TUMOR BIOLOGY
- Role of hypoxia in the hallmarks of human cancer
- (2009) Kai Ruan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Heterogeneity and Power in Clinical Biomarker Studies
- (2009) Melania Pintilie et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
- (2009) Julia Bohlius et al. LANCET
- Regulation of gene expression by hypoxia
- (2008) Niall Steven Kenneth et al. BIOCHEMICAL JOURNAL
- Abnormal mitosis in hypertetraploid cells causes aberrant nuclear morphology in association with H2O2-induced premature senescence
- (2008) Susumu Ohshima CYTOMETRY PART A
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
- (2008) Roy Vergis et al. LANCET ONCOLOGY
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now